{
    "2019-01-15": [
        [
            {
                "time": "",
                "original_text": "年报预热！机构、股东、高管争相买入这些业绩暴增股",
                "features": {
                    "keywords": [
                        "年报",
                        "机构",
                        "股东",
                        "高管",
                        "买入",
                        "业绩暴增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药类上市公司披露2018年成绩单，近八成预喜",
                "features": {
                    "keywords": [
                        "医药",
                        "上市公司",
                        "2018年",
                        "成绩单",
                        "预喜"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}